Report overview
Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the signs & symptoms of breast cancer. Breast cancer screening does not prevent the disease. However, detection in early stage increases the chances of recovery from the disease. Breast cancer screening tests are offered to women aged between 50-70 years as they are more prone to the disease.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Screening Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Screening Tests. This report contains market size and forecasts of Breast Cancer Screening Tests in global, including the following market information:
Global Breast Cancer Screening Tests Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Breast Cancer Screening Tests market was valued at US$ 1253.1 million in 2022 and is projected to reach US$ 1716 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Breast Cancer Screening Tests Market is primarily driven by a few key factors such as the patient awareness regarding rising healthcare concerns, increasing research for detection of various types of cancers, and prevention of disease. In addition to this, Breast Cancer Screening Tests Market also observes significant growth due to different government initiatives and public awareness campaigns.
We surveyed the Breast Cancer Screening Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Screening Tests Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Screening Tests Market Segment Percentages, by Type, 2022 (%)
Physical Exam
Laboratory Tests
Imaging Tests
Genetic Tests
Global Breast Cancer Screening Tests Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Screening Tests Market Segment Percentages, by Application, 2022 (%)
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Global Breast Cancer Screening Tests Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Breast Cancer Screening Tests Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Screening Tests revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Breast Cancer Screening Tests revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hologic
Siemens Healthcare
Carestream Health
Philips Healthcare
Shimadzu Corporation
Canon Medical Systems
Hitachi Medical Corporation
Esaote
Agilent Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Breast Cancer Screening Tests, market overview.
Chapter 2: Global Breast Cancer Screening Tests market size in revenue.
Chapter 3: Detailed analysis of Breast Cancer Screening Tests company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Cancer Screening Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
